8/2/2013

The FDA granted final approval to Perrigo's abbreviated new drug application for a generic version of fluticasone propionate lotion 0.05%, or cutivate lotion 0.05%. The treatment is indicated for the pruritic and inflammatory symptoms of atopic dermatitis in patients 1 year and older.

Related Summaries